NASDAQ
PRE
Last Price
US $19.7
Valuation
Financial
Performance
Cash flow to debt coverage
Prenetics Global Limited cash flow to debt ratio of -989.61% indicates that the company cannot generate enough cash to cover its debt over time. This level indicates weak financial health.
Free cash flow growth
Prenetics Global Limited's free cash flow has increased -26.45% from $-29.94M last year to $-22.02M, signaling increasing performance
Debt-to-equity ratio
Prenetics Global Limited's debt to equity ratio is 0.00, which means that the company's assets are healthy financed, signaling financial stability.
Debt-to-equity trend
Prenetics Global Limited's debt has decreased relative to shareholder equity from 0.03 last year to 0.00 today, signaling strengthened financials
Net debt to EBITDA
Prenetics Global Limited has a net cash position, so leverage is healthy.
Interest coverage
Prenetics Global Limited earns at least as much interest as it pays. Interest obligations are fully covered.
Profit margin growth
Prenetics Global Limited's profit margin has increased (-58.70%) in the last year from -151.22% to -62.45%, signaling increasing performance
Current ratio
Prenetics Global Limited's short-term assets of $83.39M exceed its short-term liabilities of $27.67M
Return on assets
Prenetics Global Limited's return on assets of 0.00% is lower than the 5.00% threshold, indicating inefficient asset utilization
Return on equity
Prenetics Global Limited's return on equity of -46.74%, is lower than 15.00%, indicating bad performance
Earnings quality
Prenetics Global Limited's operating cash flow is lower than its net income, indicating that earnings may not be fully backed by cash generation
Earnings stability
Prenetics Global Limited had positive net income in only 0 out of 5 years, indicating unstable earnings
Positive free cash flow
Prenetics Global Limited has negative free cash flow, indicating the company is burning cash rather than generating it
Free cash flow yield
Prenetics Global Limited has negative free cash flow, indicating cash burn
Earnings growth
Prenetics Global Limited's yearly earnings has increased -18.56% since last year from $-46.30M to $-37.71M, signaling increasing performance
Revenue growth
Prenetics Global Limited's yearly revenue has increased 201.72% since last year from $30.62M to $92.39M, signaling increasing performance
Return on invested capital
ROIC -25.54% (Source: FMP key-metrics). Below the 5% partial-credit threshold. Score: 0 of 2. The 5% and 10% cutoffs anchor to typical US weighted-average cost of capital. Below 5% indicates the company is not generating returns above its likely cost of capital under this definition of invested capital. Invested capital here includes equity, non-current liabilities (pension obligations, deferred taxes, lease obligations), and short-term debt. Cash is not subtracted. Companies with substantial float, lease portfolios, or cash holdings will score lower under this definition than under narrower operating-capital definitions. See methodology.
3-year revenue CAGR
Prenetics Global Limited's 3-year revenue CAGR of 91.46% is positive, indicating growing revenue over the past 3 years
Revenue consistency
Prenetics Global Limited had revenue growth in 4 out of 5 years, indicating consistent revenue performance
Return on equity consistency
Prenetics Global Limited had positive ROE in only 0 out of 5 years, indicating inconsistent returns on equity
Cash Flow Valuation (DCF)
Prenetics Global Limited has insufficient data to evaluate this check.
Earnings yield (TTM)
Prenetics Global Limited has negative trailing-twelve-month earnings; this ratio is not meaningful and the check fails
EBITDA Valuation
Prenetics Global Limited is overvalued relative to its fair value price of 0.00 based on EBITDA multiple model
EV/EBITDA (FY)
Prenetics Global Limited has negative or missing EBITDA, making EV/EBITDA ratio unreliable
PEG ratio (TTM/FY)
Prenetics Global Limited has negative trailing-twelve-month earnings; this ratio is not meaningful and the check fails
Price-to-book ratio (FY)
Prenetics Global Limited has a price-to-book ratio of 2.64x, which is below the 5.00x threshold, indicating reasonable valuation relative to its book value
Price-to-sales ratio (TTM)
Prenetics Global Limited has a price-to-sales ratio of 2.81x, which is below the 8.00x threshold, indicating reasonable valuation relative to its revenue
Profit margin
Current Ratio
Capital Returns
-46.74%
Return on equity
ROIC: -25.54%
Valuation History
-
Price to Earnings
EV/EBITDA: -5.4X
Cash flow
Profit margin
-46.46%
Cash flow
-23.05%
Fair Value
Market $19.7
—
Default assumptions
Base valuations use default assumptions. Customize in the Valuator.